Natalizumab: Benefit outweighs risk in selected patients with multiple sclerosis

J. Theodore Phillips, Elliot Frohman

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)151-153
Number of pages3
JournalTherapeutic Advances in Neurological Disorders
Issue number3
StatePublished - Nov 2008

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology

Cite this